Status:

RECRUITING

Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

Lead Sponsor:

SciClone Pharmaceuticals

Conditions:

ESR1 Gene Mutation

Advanced Breast Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

This study is a prospective non-interventional real-world study enrolling patients with advanced breast cancer who are ER+/HER2- and have ESR1- gene mutations, collecting information on patients' comp...

Eligibility Criteria

Inclusion

  • 1\. must have a histologically or cytologically confirmed diagnosis of breast cancer with evidence of locally advanced disease unsuitable for excision or radical radiotherapy, or evidence of metastatic disease unsuitable for radical treatment.
  • 2\. female ≥ 18 years of age
  • 3\. female subjects must be postmenopausal (meeting any of the following criteria is sufficient) a) Has undergone oophorectomy. b) Age ≥ 60 years. c) 40 years old \< age ≤ 60 years old with 1 year of menopause. d) Age \<60 years and receiving ovarian suppression therapy.
  • 4\. ER-positive and HER2-negative status and ESR1-mutation positive must be confirmed.
  • 5\. must have progressed on at least one line of endocrine therapy prior to enrollment, including monotherapy or combination therapy.
  • 6\. have normal organ function (as assessed by the investigator).

Exclusion

  • 1\. women who are pregnant or breastfeeding
  • 2\. known difficulties in tolerating oral medications, or conditions that interfere with the absorption of oral medications or allergies to medications and their excitements
  • 3\. other conditions that make enrollment in the study unsuitable, at the discretion of the investigator

Key Trial Info

Start Date :

July 13 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2026

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT06544577

Start Date

July 13 2024

End Date

August 1 2026

Last Update

August 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hainan Hospital of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Boao Research Hospital, Hainan)

Qionghai, Hainan, China